RE: Research Report.............
Hey thats right polak.......those events will help the PPS surge .
I'm still a believer that when the American Analysts Initiate Coverage for Transition on the Nasdaq they will not use such low Market Penetration percentages as they did with this report and other Canadian Reports.
......2.7% in the third year & 4.5% in year 5 for US and EU is ridiculous for a disease modifying Drug!! ........Try 5% in year 1, if not 10%!! And thats being conservative with a couple other AD Drugs on the market to boot.
Yup I can say it ........Gastrin gets its own Stand Alone Phasell and here's a quote from the last webcast from Dr. Cruz in regards to the Phasell's for which the Protocols have been Submitted....""We are coming to the conclusion , actually from the animal studies that we have, that G1 (Gastrin) Alone is capable of stimulating Beta Cell Activity and once you do That, it is sustained."
.....this to me is a major achievement and a surprise twist to the tale of the little biotech from Canada.
So yes........BoooooooYaaaaaaaaaHHHHH 's !!!!!.........are in order!!!!